Growth Metrics

Bio-Techne (TECH) Other financing activities (2016 - 2022)

Bio-Techne has reported Other financing activities over the past 14 years, most recently at -$2.5 million for Q3 2022.

  • Quarterly results put Other financing activities at -$2.5 million for Q3 2022, down 113.43% from a year ago — trailing twelve months through Jun 2023 was -$2.5 million (down 108.84% YoY), and the annual figure for FY2023 was -$2.5 million, down 411.8%.
  • Other financing activities for Q3 2022 was -$2.5 million at Bio-Techne, down from $3.4 million in the prior quarter.
  • Over the last five years, Other financing activities for TECH hit a ceiling of $18.3 million in Q3 2021 and a floor of -$4.9 million in Q3 2020.
  • Median Other financing activities over the past 5 years was $2.8 million (2019), compared with a mean of $3.5 million.
  • Biggest five-year swings in Other financing activities: crashed 2437.21% in 2018 and later soared 1133.33% in 2019.
  • Bio-Techne's Other financing activities stood at $300000.0 in 2018, then soared by 1133.33% to $3.7 million in 2019, then grew by 29.73% to $4.8 million in 2020, then rose by 27.08% to $6.1 million in 2021, then crashed by 140.28% to -$2.5 million in 2022.
  • The last three reported values for Other financing activities were -$2.5 million (Q3 2022), $3.4 million (Q1 2022), and $6.1 million (Q4 2021) per Business Quant data.